Literature DB >> 17145767

RANK overexpression in transgenic mice with mouse mammary tumor virus promoter-controlled RANK increases proliferation and impairs alveolar differentiation in the mammary epithelia and disrupts lumen formation in cultured epithelial acini.

Eva Gonzalez-Suarez1, Daniel Branstetter, Allison Armstrong, Huyen Dinh, Hal Blumberg, William C Dougall.   

Abstract

RANK and RANKL, the key regulators of osteoclast differentiation and activation, also play an important role in the control of proliferation and differentiation of mammary epithelial cells during pregnancy. Here, we show that RANK protein expression is strictly regulated in a spatial and temporal manner during mammary gland development. RANK overexpression under the control of the mouse mammary tumor virus (MMTV) promoter in a transgenic mouse model results in increased mammary epithelial cell proliferation during pregnancy, impaired differentiation of lobulo-alveolar structures, decreased expression of the milk proteins beta-casein and whey acidic protein, and deficient lactation. We also show that treatment of three-dimensional in vitro cultures of primary mammary cells from MMTV-RANK mice with RANKL results in increased proliferation and decreased apoptosis in the luminal area, resulting in bigger acini with filled lumens. Taken together, these results suggest that signaling through RANK not only promotes proliferation but also inhibits the terminal differentiation of mammary epithelial cells. Moreover, the increased proliferation and survival observed in a three-dimensional culture system suggests a role for aberrant RANK signaling during breast tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17145767      PMCID: PMC1800710          DOI: 10.1128/MCB.01298-06

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  47 in total

1.  Dynamic expression and activity of NF-kappaB during post-natal mammary gland morphogenesis.

Authors:  D M Brantley; F E Yull; R S Muraoka; D J Hicks; C M Cook; L D Kerr
Journal:  Mech Dev       Date:  2000-10       Impact factor: 1.882

2.  Gene expression of osteoprotegerin ligand, osteoprotegerin, and receptor activator of NF-kappaB in giant cell tumor of bone: possible involvement in tumor cell-induced osteoclast-like cell formation.

Authors:  L Huang; J Xu; D J Wood; M H Zheng
Journal:  Am J Pathol       Date:  2000-03       Impact factor: 4.307

3.  The osteoclast differentiation factor osteoprotegerin-ligand is essential for mammary gland development.

Authors:  J E Fata; Y Y Kong; J Li; T Sasaki; J Irie-Sasaki; R A Moorehead; R Elliott; S Scully; E B Voura; D L Lacey; W J Boyle; R Khokha; J M Penninger
Journal:  Cell       Date:  2000-09-29       Impact factor: 41.582

4.  Regulation of cancer cell migration and bone metastasis by RANKL.

Authors:  D Holstead Jones; Tomoki Nakashima; Otto H Sanchez; Ivona Kozieradzki; Svetlana V Komarova; Ildiko Sarosi; Sean Morony; Evelyn Rubin; Renu Sarao; Carlo V Hojilla; Vukoslav Komnenovic; Young-Yun Kong; Martin Schreiber; S Jeffrey Dixon; Stephen M Sims; Rama Khokha; Teiji Wada; Josef M Penninger
Journal:  Nature       Date:  2006-03-30       Impact factor: 49.962

Review 5.  Prostate carcinoma: production of bioactive factors.

Authors:  L J Deftos
Journal:  Cancer       Date:  2000-06-15       Impact factor: 6.860

6.  Over-expression of erbB-2/neu is paralleled by inhibition of mouse-mammary-epithelial-cell differentiation and developmental apoptosis.

Authors:  H Lazar; A Baltzer; C Gimmi; A Marti; R Jaggi
Journal:  Int J Cancer       Date:  2000-02-15       Impact factor: 7.396

7.  Therapeutic efficacy of a soluble receptor activator of nuclear factor kappaB-IgG Fc fusion protein in suppressing bone resorption and hypercalcemia in a model of humoral hypercalcemia of malignancy.

Authors:  B O Oyajobi; D M Anderson; K Traianedes; P J Williams; T Yoneda; G R Mundy
Journal:  Cancer Res       Date:  2001-03-15       Impact factor: 12.701

8.  Expression of a truncated Int3 gene in developing secretory mammary epithelium specifically retards lobular differentiation resulting in tumorigenesis.

Authors:  D Gallahan; C Jhappan; G Robinson; L Hennighausen; R Sharp; E Kordon; R Callahan; G Merlino; G H Smith
Journal:  Cancer Res       Date:  1996-04-15       Impact factor: 12.701

9.  Commitment and differentiation of osteoclast precursor cells by the sequential expression of c-Fms and receptor activator of nuclear factor kappaB (RANK) receptors.

Authors:  F Arai; T Miyamoto; O Ohneda; T Inada; T Sudo; K Brasel; T Miyata; D M Anderson; T Suda
Journal:  J Exp Med       Date:  1999-12-20       Impact factor: 14.307

Review 10.  Mouse models for breast cancer.

Authors:  L Hennighausen
Journal:  Breast Cancer Res       Date:  1999-12-17       Impact factor: 6.466

View more
  50 in total

1.  TNFRSF11A and TNFSF11 are associated with age at menarche and natural menopause in white women.

Authors:  Yan Lu; Pengyuan Liu; Robert R Recker; Hong-Wen Deng; Volodymyr Dvornyk
Journal:  Menopause       Date:  2010 Sep-Oct       Impact factor: 2.953

2.  Stem cells: Cues from steroid hormones.

Authors:  John P Lydon
Journal:  Nature       Date:  2010-06-10       Impact factor: 49.962

Review 3.  RANKL inhibition: a promising novel strategy for breast cancer treatment.

Authors:  Eva González-Suárez
Journal:  Clin Transl Oncol       Date:  2011-04       Impact factor: 3.405

4.  Circulating RANKL and RANKL/OPG and Breast Cancer Risk by ER and PR Subtype: Results from the EPIC Cohort.

Authors:  Danja Sarink; Helena Schock; Theron Johnson; Kim Overvad; Marianne Holm; Anne Tjønneland; Marie-Christine Boutron-Ruault; Mathilde His; Marina Kvaskoff; Heiner Boeing; Pagona Lagiou; Eleni-Maria Papatesta; Antonia Trichopoulou; Domenico Palli; Valeria Pala; Amalia Mattiello; Rosario Tumino; Carlotta Sacerdote; H B As Bueno-de-Mesquita; Carla H van Gils; Petra H Peeters; Elisabete Weiderpass; Antonio Agudo; Maria-José Sánchez; Maria-Dolores Chirlaque; Eva Ardanaz; Pilar Amiano; Kay Tee Khaw; Ruth Travis; Laure Dossus; Mark Gunter; Sabina Rinaldi; Melissa Merritt; Elio Riboli; Rudolf Kaaks; Renée T Fortner
Journal:  Cancer Prev Res (Phila)       Date:  2017-07-12

5.  Control of mammary stem cell function by steroid hormone signalling.

Authors:  Marie-Liesse Asselin-Labat; François Vaillant; Julie M Sheridan; Bhupinder Pal; Di Wu; Evan R Simpson; Hisataka Yasuda; Gordon K Smyth; T John Martin; Geoffrey J Lindeman; Jane E Visvader
Journal:  Nature       Date:  2010-04-11       Impact factor: 49.962

6.  Loss of glutaredoxin 3 impedes mammary lobuloalveolar development during pregnancy and lactation.

Authors:  Khanh Pham; Jie Dong; Xiqian Jiang; Ying Qu; Han Yu; Yisheng Yang; Walter Olea; Juan C Marini; Lawrence Chan; Jin Wang; Xander H T Wehrens; Xiaojiang Cui; Yi Li; Darryl L Hadsell; Ninghui Cheng
Journal:  Am J Physiol Endocrinol Metab       Date:  2016-11-15       Impact factor: 4.310

7.  Signal transducer and activator of transcription 5a mediates mammary ductal branching and proliferation in the nulliparous mouse.

Authors:  Sarah J Santos; Sandra Z Haslam; Susan E Conrad
Journal:  Endocrinology       Date:  2010-04-14       Impact factor: 4.736

Review 8.  Progesterone signalling in breast cancer: a neglected hormone coming into the limelight.

Authors:  Cathrin Brisken
Journal:  Nat Rev Cancer       Date:  2013-06       Impact factor: 60.716

9.  Progestin-regulated luminal cell and myoepithelial cell-specific responses in mammary organoid culture.

Authors:  Sandra Z Haslam; Alexis Drolet; Kyle Smith; May Tan; Mark Aupperlee
Journal:  Endocrinology       Date:  2008-01-24       Impact factor: 4.736

Review 10.  Prolactin regulation of mammary gland development.

Authors:  Samantha R Oakes; Renee L Rogers; Matthew J Naylor; Christopher J Ormandy
Journal:  J Mammary Gland Biol Neoplasia       Date:  2008-01-25       Impact factor: 2.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.